Gastric Acid Resistance Testing of Raw Materials: Methods, Standards, and Applications

Gastric acid resistance testing evaluates whether raw materials such as probiotic cultures, microencapsulated actives, and enteric-coated ingredients can survive the harsh acidic environment of the human stomach before reaching their target site of action. Performed by ISO/IEC 17025-accredited third-party laboratories using simulated gastric fluid, this test delivers critical data for formulation design, quality control, supplier qualification, and regulatory submissions. This guide explains the technical principles, sample types, testing items, methodologies, and practical applications of raw material gastric acid resistance performance testing.

Technical Overview

The human stomach is one of the most aggressive chemical environments that an ingested material can encounter. In the fasting state, gastric juice typically exhibits a pH between 1.5 and 3.5, and under worst-case conditions the pH can approach 1.0 to 2.0, with gastric residence times ranging from approximately 30 minutes to 3 hours depending on the dosage form and fed/fasted state. For many functional raw materials, particularly live microorganisms, enzymes, proteins, peptides, and certain bioactive compounds, this acidic barrier represents the single largest threat to in vivo performance.

Gastric acid resistance testing is an in vitro laboratory procedure that reproduces these conditions in a controlled manner. Samples are exposed to simulated gastric fluid (SGF), a buffered or acidified medium containing pepsin at physiological temperature (37 °C), and their survival, stability, or release behavior is quantified over defined time intervals. For probiotic raw materials, the key endpoint is the viable cell count after acid exposure; for coated or encapsulated ingredients, the endpoint may be the dissolution or release profile in the acid stage; for sensitive active compounds, the endpoint is often assay retention measured by chromatographic or spectroscopic methods.

The resulting data allow manufacturers to make evidence-based decisions on enteric coating selection, microencapsulation technology, dosage form design, and recommended intake timing. Testing is typically conducted in accredited third-party laboratories operating under ISO/IEC 17025 quality management systems, using simulated fluid formulations consistent with internationally recognized pharmacopoeial practices and enumeration methods aligned with ISO and GB standards.

Testing Samples

Probiotic Powders and Microbial Concentrates

Freeze-dried probiotic powders, direct vat inoculant (DVI) cultures, fermentation concentrates, and microencapsulated bacterial preparations are the most frequently tested sample category. Typical materials include Lactobacillus, Bifidobacterium, Streptococcus, and Bacillus species with declared potencies ranging from 10⁹ to 10¹¹ CFU/g. Because live microorganisms must survive gastric transit to colonize or act in the intestine, acid resistance is a core quality attribute for these raw materials.

Microencapsulated and Enteric-Coated Ingredients

Raw materials protected by alginate beads, cellulose derivatives, starch matrices, lipid coatings, or pH-sensitive acrylic polymers are tested to verify that the protective barrier performs as intended. The test confirms that the coating remains intact in acid and releases its payload only under near-neutral intestinal conditions.

Tablets, Capsules, and Solid Dosage Forms

Compressed tablets, hard and soft capsules, granules, pellets, and sachet products containing acid-labile ingredients can be evaluated as representative prototypes or finished forms. For delayed-release products, acid-stage testing demonstrates that no more than a defined percentage of the active is released during the simulated gastric phase.

Functional Food and Nutraceutical Raw Materials

Enzyme preparations, protein hydrolysates, bioactive peptides, botanical extracts, omega-3 oils, vitamins, and mineral compounds may degrade, oxidize, or precipitate under gastric pH. Gastric acid resistance testing quantifies the retention of active marker compounds after acid exposure and supports stability claims for functional formulations.

Pharmaceutical Active Ingredients and Excipients

Active pharmaceutical ingredients (APIs) with known acid lability, as well as novel excipients intended for enteric or delayed-release applications, are characterized for acid-stage stability and release behavior as part of preformulation and excipient qualification studies.

Testing Items

Depending on the nature of the raw material and the objective of the study, the following parameters are commonly evaluated:

• Viable cell count before and after acid exposure, expressed in CFU/g or CFU/mL
• Survival rate (%) and log₁₀ reduction value after defined exposure intervals
• Acid tolerance curve across multiple pH levels (typically pH 1.2, 2.0, 3.0) and time points (0 to 180 minutes)
• Acid-stage dissolution and cumulative release profile of coated or encapsulated materials
• Disintegration behavior and disintegration time in acidic medium
• Assay retention of active marker compounds, quantified by HPLC, UV-Vis, or other validated analytical methods
• Acid uptake, mass change, and surface morphology of coated particles or beads
• Sequential gastrointestinal transit survival, combining a gastric phase in SGF followed by an intestinal phase in simulated intestinal fluid (SIF)

Testing Methods

Preparation of Simulated Gastric Fluid

Simulated gastric fluid is prepared according to established pharmacopoeial formulations, typically containing sodium chloride (approximately 2 g/L) and pepsin (approximately 3.2 g/L), adjusted to the target pH with hydrochloric acid. A pH of 1.2 represents a worst-case fasting stomach environment, while pH 2.0 to 3.0 represents typical physiological conditions. The medium is pre-warmed and maintained at 37 ± 1 °C throughout the test to mimic body temperature.

Static In Vitro Exposure Assay

The test sample is introduced into the simulated gastric fluid at a defined ratio (for example, 1 g of sample per 100 mL of medium) and incubated at 37 °C with gentle agitation. Aliquots are withdrawn at predetermined time points, commonly 0, 30, 60, 120, and 180 minutes. For microbial samples, withdrawn aliquots are immediately neutralized with sodium bicarbonate solution or phosphate buffer to halt the acid reaction before enumeration.

Enumeration and Survival Calculation

For probiotic and microbial raw materials, serial dilutions are prepared and plated using appropriate selective or non-selective media. Enumeration of lactic acid bacteria may follow ISO 15214 or GB 4789.35 methodology, and enumeration of presumptive bifidobacteria may follow ISO 29981, with anaerobic incubation at 37 °C for 48 to 72 hours. The results are calculated as follows:

• Survival rate (%) = (CFU at time t / CFU at time 0) × 100
• Log reduction = log₁₀ (CFU at time 0) − log₁₀ (CFU at time t)

A log reduction of no more than 1.0, corresponding to a survival rate of at least 10% and commonly benchmarked against a 50% threshold depending on the specification, is frequently adopted as an acceptance criterion after 2 to 3 hours of exposure at pH 3.0, though criteria are ultimately defined by the client or product specification.

Dissolution and Release Testing

For coated, encapsulated, and delayed-release materials, dissolution testing is performed using standard basket, paddle, or flow-through apparatus. The acid stage is typically conducted in SGF at pH 1.2 for up to 2 hours, with samples withdrawn at intervals and analyzed by UV-Vis or HPLC to generate a cumulative release profile. Materials intended for intestinal delivery should release only a minimal fraction of their payload during this acid phase.

Sequential Gastrointestinal Transit Model

To reflect the complete digestive journey, a two-phase model may be applied: the sample is first exposed to SGF for 2 to 3 hours, then transferred without loss into simulated intestinal fluid at pH 6.8 containing pancreatin and bile salts for a further 2 to 4 hours. This approach distinguishes materials that merely survive acid exposure from those that also release their active payload under intestinal conditions.

Data Reporting and Quality Assurance

The final test report documents the simulated fluid formulation, pH verification, temperature, exposure timeline, analytical methods, raw data, calculated survival or release values, and interpretation against acceptance criteria. Tests performed in ISO/IEC 17025-accredited third-party laboratories provide independent, traceable results suitable for supplier qualification, claim substantiation, and regulatory documentation.

Applications

Gastric acid resistance testing serves a wide range of practical purposes across the food, nutraceutical, and pharmaceutical supply chains:

• Formulation screening: comparing candidate strains, coatings, and excipients during early product development
• Microencapsulation and enteric coating validation: verifying that protective technologies achieve their intended acid barrier performance
• Incoming raw material quality control: setting and verifying acid resistance specifications for purchased probiotic and functional ingredients
• Supplier comparison: benchmarking equivalent raw materials from different sources under identical test conditions
• Claim substantiation: providing laboratory evidence for acid-resistant, gastro-protected, or delivery-targeted marketing claims
• Regulatory support: supplying technical data for product registration files and labeling documentation
• Stability programs: confirming that gastric acid resistance is maintained throughout the shelf life of the raw material or finished product
• Research and development: evaluating novel delivery systems such as alginate microspheres, liposomes, and pH-responsive polymer coatings

FAQ

Why is gastric acid resistance important for raw materials?

Many functional raw materials, especially live probiotics and acid-labile actives, are inactivated or degraded in the stomach before they can exert their intended effect. Demonstrating gastric acid resistance confirms that a material can deliver its functional payload past the stomach to the intestine, which is essential for product efficacy.

What pH conditions are used in the test?

Simulated gastric fluid at pH 1.2 is used to model a worst-case fasting stomach, while pH 2.0 to 3.0 represents typical physiological conditions. Multiple pH levels can be tested in parallel to generate a complete acid tolerance profile, and custom pH values can be accommodated for specific research objectives.

How long are samples exposed to simulated gastric fluid?

Exposure durations of 2 to 3 hours are most common, reflecting typical gastric residence times, with intermediate sampling points at 30, 60, and 120 minutes. Extended or shortened exposure protocols can be designed to match specific product-use scenarios.

What is considered a passing result?

Acceptance criteria are defined by the client or product specification. For probiotic raw materials, a log reduction of no more than 1.0 after 2 to 3 hours at pH 3.0 is a widely used benchmark, and many suppliers target survival rates of 50% or higher. For delayed-release materials, the criterion is typically a release of no more than 10% of the active during the 2-hour acid stage.

Which standards and references apply to this testing?

Simulated fluid preparation follows internationally recognized pharmacopoeial formulations, microbial enumeration follows ISO and GB horizontal methods such as ISO 15214, ISO 29981, and GB 4789.35 where applicable, and testing is conducted within ISO/IEC 17025-accredited third-party laboratories to ensure method validity and data traceability.

Can finished products be tested in addition to raw materials?

Yes. The same methodology applies to finished capsules, tablets, powders, and functional foods. Testing finished products confirms that downstream processing, packaging, and storage have not compromised the gastric acid resistance originally demonstrated by the raw material.

What sample quantity and turnaround time are typical?

For microbial testing, approximately 50 to 100 grams of raw material per test condition is generally sufficient, accounting for replicate analysis. Standard turnaround is typically 10 to 15 working days after sample receipt, depending on incubation requirements and the complexity of the test design.